title: Sesamin attenuates intercellular cell adhesion molecule-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in apolipoprotein-E-deficient mice.
authors.affiliation: Department of Human Development and Family Studies, National Taiwan Normal University, Taipei, Taiwan.
authors.forename: Wen-Huey
authors.initials: WH
authors.lastname: Wu
authors.forename: Shu-Huei
authors.initials: SH
authors.lastname: Wang
authors.forename: I-I
authors.initials: II
authors.lastname: Kuan
authors.forename: Ya-Shi
authors.initials: YS
authors.lastname: Kao
authors.forename: Pei-Jhen
authors.initials: PJ
authors.lastname: Wu
authors.forename: Chan-Jung
authors.initials: CJ
authors.lastname: Liang
authors.forename: Hsiung-Fei
authors.initials: HF
authors.lastname: Chien
authors.forename: Chiu-Hua
authors.initials: CH
authors.lastname: Kao
authors.forename: Ching-Jang
authors.initials: CJ
authors.lastname: Huang
authors.forename: Yuh-Lien
authors.initials: YL
authors.lastname: Chen
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology / Q000627:therapeutic use; D000954:Antigens, Surface / Q000235:genetics / Q000378:metabolism; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use; D001011:Aorta / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D001057:Apolipoproteins E / Q000235:genetics; D050197:Atherosclerosis / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D052117:Benzodioxoles / Q000494:pharmacology; D002460:Cell Line; D002478:Cells, Cultured; D004149:Dioxoles / Q000494:pharmacology* / Q000627:therapeutic use*; D051959:ELAV Proteins; D000067780:ELAV-Like Protein 1; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics / Q000378:metabolism*; D017705:Lignans / Q000494:pharmacology* / Q000627:therapeutic use*; D051379:Mice; D018345:Mice, Knockout; D009000:Monocytes / Q000187:drug effects; D010636:Phenols / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D034741:RNA, Small Interfering; D016601:RNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D011897:Random Allocation; D015398:Signal Transduction / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000954:Antigens, Surface; D000975:Antioxidants; D001057:Apolipoproteins E; D052117:Benzodioxoles; D004149:Dioxoles; D051959:ELAV Proteins; D000067780:ELAV-Like Protein 1; C098770:ELAVL1 protein, human; D017705:Lignans; D010636:Phenols; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D016601:RNA-Binding Proteins; D014409:Tumor Necrosis Factor-alpha; D018799:Intercellular Adhesion Molecule-1; C025583:sesamol; C054125:sesamin